Oxygenta Pharmaceutical Limited (OXYGENTAPH.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹46.77 (-2.56%) as of
Key statistics
- Market cap
- 1.73B
- EPS (TTM)
- -3.67
- Dividend yield
- 0.00%
- 52-week range
- 43.00 – 71.59
- Beta
- 0.80
- Revenue (TTM)
- 1.35B
- Profit margin
- -10.04%
- Volume
- 6.00k
About Oxygenta Pharmaceutical Limited
Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers active pharmaceuticals ingredients, commercial intermediates, and organic fine chemicals, as well as formulations. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India. Oxygenta Pharmaceutical Limited operates as a subsidiary of Virupaksha Organics Limited.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Hyderabad, India
- Employees
- 170
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.